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Hantaviruses cause hemorrhagic fever with renal syndrome (HFRS) and hantavirus
cardiopulmonary syndrome (HCPS) in humans. Both diseases are considered to be
immunologically mediated but the exact pathological mechanisms are still poorly
understood. Neutrophils are considered the first line of defense against invadingmicrobes
but little is still known of their role in virus infections. We wanted to study the role of
neutrophils in HFRS using blood and tissue samples obtained from Puumala hantavirus
(PUUV)-infected patients. We found that neutrophil activation products myeloperoxidase
and neutrophil elastase, together with interleukin-8 (the major neutrophil chemotactic
factor in humans), are strongly elevated in blood of acute PUUV-HFRS and positively
correlate with kidney dysfunction, the hallmark clinical finding of HFRS. These markers
localized mainly in the tubulointerstitial space in the kidneys of PUUV-HFRS patients
suggesting neutrophil activation to be a likely component of the general immune response
toward hantaviruses. We also observed increased levels of circulating extracellular
histones at the acute stage of the disease supporting previous findings of neutrophil
extracellular trap formation in PUUV-HFRS. Mechanistically, we did not find evidence for
direct PUUV-mediated activation of neutrophils but instead primary blood microvascular
endothelial cells acquired a pro-inflammatory phenotype and promoted neutrophil
degranulation in response to PUUV infection in vitro. These results suggest that
neutrophils are activated by hantavirus-infected endothelial cells and may contribute to
the kidney pathology which determines the severity of HFRS.
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INTRODUCTION
Hantaviruses are the causative agents of two human diseases: hemorrhagic fever with renal
syndrome (HFRS) in Eurasia and hantavirus cardiopulmonary syndrome (HCPS) in the Americas.
Each hantavirus species is carried by its specific rodent host with no or minimal signs of disease but
cause occasional human spillover infections with immune-mediated pathology (1). A hallmark of
both hantavirus diseases is increased vascular permeability which mediates kidney and lung failure
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associated with HFRS and HCPS, respectively (1). Endothelial
cells lining the vasculature are also the prime target of viral
replication in patients (2, 3). Puumala hantavirus (PUUV)
circulates in Northern Europe and Russia causing a relatively
mild form of HFRS as compared to Hantaan (HTNV) or
Dobrava hantavirus (DOBV)-caused HFRS and especially Andes
(ANDV)- or Sin Nombre (SNV)-caused HCPS in which fatality
rates can reach 40% (4).
Typical laboratory findings in acute PUUV-caused
HFRS are leukocytosis, thrombocytopenia, increased C-
reactive protein (CRP) level, and as signs of acute kidney
injury (AKI), proteinuria, haematuria and elevated serum
creatinine concentration (5). In addition to thrombocytopenia,
hematological abnormalities include increased coagulation and
fibrinolysis, complement activation, and elevated levels of pro-
inflammatory cytokines which all have the potential to contribute
to vascular permeability. Vascular permeability, in turn, could
be the underlying cause of proteinuria which typically precedes
AKI (6). The pathophysiology of PUUV-HFRS associated AKI is
usually described as tubulointerstitial nephritis and infiltration of
several immune cell types such as lymphocytes, monocytes, and
polymorphonuclear leukocytes into kidneys have been observed
(7, 8).
Neutrophils are the most abundant circulating leukocytes in
humans and play a fundamental role in the innate immune
response (9). Circulating neutrophils are the first type of immune
cells recruited to sites of inflammation or infection. In humans,
one of the most important chemotactic factors for neutrophils
is interleukin (IL)-8, released at the site inflammation/infection
(10). After receiving chemotactic signals neutrophils interact
with endothelial cells lining the vasculature in order to traverse
the endothelium and into the inflamed tissues (11). In vivo,
the interactions between neutrophils and endothelial cells
include initial rolling followed by firm adhesion and finally
transendothelial migration. Firm adhesion is facilitated, among
other factors, by endothelial intercellular adhesion molecule
(ICAM)-1 expressed on the surface of endothelial cells and
CD11b/CD18 integrin complex (also known as Mac-1, CR3 or
αMβ2) on neutrophils (12). Once neutrophils reach the site of
infection their primary role is to kill invading microbes by
production of reactive oxygen species (ROS) and the release
of antimicrobial proteins such as myeloperoxidase (MPO) and
human neutrophil elastase (HNE) in a process of degranulation
(13, 14). In addition to ROS formation and degranulation,
neutrophils are also able to release neutrophil extracellular traps
(NETs), consisting of extracellular chromatin decorated with
histones and granular proteins such as MPO and HNE, and with
the potential to entrap and kill pathogens (15, 16).
The activation of neutrophils in several bacterial infections
is well-described but their role in virus-mediated diseases
has been neglected to a large extent (17). The involvement
of neutrophils in the pathogenesis of hantavirus diseases is
suggested by acutely increased serum levels of cytokines and
chemokines with known functions in neutrophil chemotaxis,
differentiation and mobilization (18–20). Increased numbers of
circulating histones, cell-fee DNA and histone-DNA complexes
have been described in the acute stage of PUUV infection
(21–23), suggesting that neutrophils release NETs during HFRS.
NETosis could potentially explain capillary leakage in HFRS
(24). Interestingly, neutrophils are crucial for increased vascular
permeability observed in response to HTNV infection in SCID
mice (25). Furthermore, HTNV has also been shown to cause
NETosis in vitro (21).
In this study we wanted to elucidate the role of neutrophil
activation in HFRS by determining markers of neutrophil
activation (MPO, HNE, histones, and IL-8) in blood and
tissues of patients suffering from acute PUUV-caused HFRS. In
addition, to directly determine the role that hantavirus plays in
mediating neutrophil responses in PUUV-HFRS, we investigated
the potential of purified PUUV or PUUV-infected endothelial
cells to activate neutrophils in vitro. Taken together, we found
that the levels of circulating and tissue-localized MPO, HNE
and IL-8 are elevated in acute PUUV-HFRS and correlate with
kidney dysfunction, thereby corroborating the role of neutrophils
in hantavirus pathogenesis. Mechanistically, our results do not
support direct virus-mediated neutrophil activation but rather an
indirect mechanism through infected endothelial cells. Finally,
the antiviral function of neutrophils was pinpointed strongly to
the release of proteases from neutrophils.
MATERIALS AND METHODS
Patient Samples
The study was approved by the Ethics Committee of Tampere
University Hospital (Nos. 99256 and R04180). All subjects gave
written informed consent in accordance with the Declaration of
Helsinki. The study consisted of plasma samples from patients
treated for serologically confirmed acute PUUV infection at the
Tampere University Hospital, Finland, during September 2000–
March 2009. We assessed the extracellular circulating levels of
MPO, HNE, histone H3 and IL-8 in plasma samples obtained
from patients with acute PUUV-caused HFRS at 1st day of
hospitalization (acute stage; median days after onset of fever 4
± 2), early recovery phase (15–30 days after hospitalization) and
healthy controls.
The study included Boiun-fixed, paraffin-embedded kidney
biopsies obtained at Tampere University Hospital during 1985–
1987. The biopsies among patients with PUUV-HFRS were
performed for clinical reasons at the time when there was
no reliable serological test for PUUV infection available. All
these biopsies were performed during the acute phase of the
disease. The highest measured serum creatinine level of the
patients ranged from 220 to 1,050 µmol/L. The biopsy findings
were acute interstitial in two cases and acute tubulointerstitial
nephritis in three, both findings being typical for PUUV-induced
AKI (5).
PUUV-negative cases served as controls. Indications for
renal biopsies were AKI in one case, microscopic hematuria
and/or proteinuria in four cases. The biopsy findings were
normal morphology in two cases, acute tubulointerstitial
nephritis, mesangial proliferative glomerulonephritis and IgM-
glomerulonephritis in one case each. In both groups of biopsy
patients a positive (PUUV-HFRS cases) or negative (controls)
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PUUV-serology was determined using stored serum samples
obtained at the time of renal biopsy.
Primary Antibodies
Primary antibodies used in this study were rabbit polyclonal
antibodies to MPO (Thermo scientific, #RB-373-A), Histone
H3 (Abcam, #ab18521) or HNE (Abcam, #ab68672) and mouse
monoclonal antibodies to IL-8 (RnD Systems; #Mab-208), CD18
(Millipore, #TS1-18) and ICAM-1 (RnD systems, #BBIG-I1)
in addition to IgG1 isotype control (Immunotools). Rabbit
polyclonal antibodies for PUUV nucleocapsid protein and
glycoproteins have been described before (26).
Histone Quantification
Histones were measured by a dot-blot assay where 2 µl of
patient or healthy control EDTA-plasma were pipetted on
nitrocellulose membrane, air-dried and probed with Histone H3
antibody in blocking buffer [1.5% milk in Tris–EDTA–NaCl–
Tween (TENT)]. After washing with TENT, the primary antibody
was detected with IR800-conjugated anti-rabbit antibody (Li-cor)
in blocking buffer. After additional washing, signal intensity was
determined by Odyssey instrumentation (Li-cor). Recombinant




The levels of MPO, HNE, and IL-8 were measured from patient
or control plasma using ELISA kits provided by Abcam (for
MPO, HNE, and IL-8) or Immunotools (for IL-8).
Immunohistochemistry (IHC)
IHC was performed on kidney sections after heat-mediated
antigen retrieval using the protocol provided in Vectastain
ABC Elite HRP kit from Vector labs. Avidin/biotin blocking
kit, biotinylated goat anti-mouse IgG or anti-rabbit secondary
antibodies and DAB substrate were used as suggested by the
vendor (Vector labs). The mean percentage of DAB positive area
was counted from four images taken (1.5 × 1.5mm) from each
individual section using Fiji Image J software.
Cultures of Primary Blood Microvascular
Endothelial Cells (BECs)
BECs were obtained from Lonza and maintained in endothelial
basal medium (EBM-2) supplemented with SingleQuotsTM Kit
containing 5% fetal bovine serum (FBS), human endothelial
growth factor, hydrocortisone, vascular endothelial growth
factor, human fibroblast growth factor-basic, ascorbic acid, R3-
insulin like growth factor-1, gentamicin and amphotericin-B
(Lonza). For experiments the cells were used at passages 7–10.
Virus Propagation and Titration
PUUV Kazan strain was propagated in Vero E6 cells (green
monkey kidney epithelial cell line; ATCC no. CRL-1586) grown
in Minimum Essential Medium containing 10% FCS, penicillin
and streptomycin (cMEM). For experiments, PUUV was
purified from Vero E6 cell supernatant through a 30% sucrose
cushion by ultracentrifugation. Virus titers were measured by
incubating diluted virus stocks on Vero E6 cells for 24 h
at 37◦C and subsequently staining acetone-fixed cells with a
polyclonal antibody specific for PUUV nucleocapsid protein and
AlexaFluor488-conjugated secondary antibody. Focus-forming
units (FFU)/ml were counted under an UV-microscope.
Infection of BECs
Confluent BECs were infected for 1 h at 37◦C using purified
PUUVdiluted in BEC growthmedium atmultiplicity of infection
(MOI) of 10. For inactivation of PUUV, virus stocks were kept
under UV light for 30min.
Immunofluorescence
Immunofluorescence of either mock-, UV-PUUV or live
PUUV-infected BECs was performed on cells grown on
black, glass-bottomed cell culture plates. After fixation
with 4% formaldehyde, cells were permeabilized (3% BSA,
0.3% TritonX-100) for 10min and incubated with primary
antibodies to MPO, HNE, ICAM-1 or viral nucleocapsid protein
followed by appropriate Alexafluor488- or Alexafluor594-
conjugated secondary antibodies (Thermo Scientific). To stain
the nuclei, cells were incubated with Hoechst 33258. After
washing, fluorescence intensity was counted using Hidex
sense microplate reader (Hidex) and images taken using
Leica TCS SP8 X confocal microscope (Biomedicum Imaging
Unit, Biomedicum, University of Helsinki, Helsinki, Finland).
Neutrophil activation was quantitated by the percentage of
decondensed polymorphonuclear cells with simultaneous MPO
relocalization in 4 immunofluorescence images (500 × 500µm)
taken randomly from each well by confocal microscope.
PMN Cultures
Fresh blood from healthy volunteers was drawn into EDTA-
tubes and PMNs immediately isolated using Polymorphoprep
separation medium (Axis-Shield) according to manufacturer’s
protocol. PMN purity and viability were assessed by phenotypic
polymorphonuclear characterization using Hoechst 33258
fluorescence microscopy and trypan blue exclusion test,
respectively (both were routinely found to be over 90%). Isolated
PMNs were diluted into BEC growth medium (106 cells/ml)
and incubated with mock-, UV-PUUV or live PUUV-infected
BECs for 1 or 3 h at 37◦C (10 times excess PMNs over BECs).
Cells were washed and subjected directly to immunofluorescence
staining as described above for determination of PMN binding.
When PMN-BEC co-cultures were incubated in the presence
of 10µg/ml neutralizing antibodies to IL-8, CD18 or viral
glycoproteins, PMNs were pre-treated with FcR blocking reagent
(Immunostep) for 10min.
Neutrophil Activation Assays
Purified virus or virus-containing Vero E6 cell culture
supernatants were incubated with freshly isolated PMNs
(MOI 1) in cMEM for 3 h at 37◦C. The incubation time was
chosen based on the optimal time needed to detect adequate
levels of PMN activation marker expression with low concurrent
spontaneous activation due to culturing. After fixation with
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2% formaldehyde, extracellular DNA was quantitated with
the fluorescent, cell-impermeable Pico-Green dsDNA binding
reagent (Thermo Scientific) using Hidex Sense microplate
reader. Peroxidase activity was assessed from supernatants of
pelleted PMNs (400 × g 5min) by the chromogenic peroxidase
substrate 3,3′,5,5′-tetramethylbenzidine (TMB).
PUUV Viability Assay
Purified PUUV was incubated for 3 h with freshly isolated PMNs
(in a 1:1 ratio) in assay buffer (10mM Hepes pH 7,4; 150mM
NaCl). Neutrophil activator phorbol myristate acetate (PMA;
1µg/ml) and one of the following inhibitors NaN3 (0.01 or
0.002%), PMSF (0.2 or 1mM), EDTA (2mM) or DNAse I (10
U/ml) were added where indicated. After incubation, PMNs were
pelleted by centrifugation (400 × g 5min) and one third of
the supernatant used for PUUV titer measurement as described
above. The rest of the sample was used for immunoblotting by
standard procedures for PUUV structural proteins (27) using
polyclonal antibodies specific for Gn, Gc or N followed by
IRD800-conjugated secondary antibody (Li-Cor) and detection
by Odyssey.
Statistics
Significant differences between groups of normally distributed
data was assessed by student’s T-test and non-normally
distributed data by Mann-Whitney U-test or Kruskal-Wallis
H-test for multiple populations. The normality of data was
estimated by Shapiro-Wilk test. Correlations between parameters
were assessed using Spearman’s rank correlation test. All analyses
were done with SPSS software version 24 (SPSS Inc., Chicago, IL,
USA) or GraphPad prism (La Jolla, CA, United States).
RESULTS
Circulating Levels of MPO, HNE, Histones,
and IL-8 Are Elevated in Acute
PUUV-Caused HFRS
Circulating levels of MPO, HNE, histones, and IL-8 were all
significantly higher in the acute stage of the disease as compared
to the recovery stage or healthy controls (Figure 1). The levels
of all the measured markers remained elevated also in the
recovery stage as compared to controls but this difference was
not statistically significant. Strongly elevated circulating levels of
MPO and HNE suggest that neutrophils are activated in acute
PUUV-HFRS. Furthermore, increased numbers of extracellular
histones imply that neutrophil activation could, at least in part,
be due to NETosis (21). Interestingly, in the present study,
neutrophil activation was accompanied by elevated levels of IL-8,
a chemotactic and priming factor for neutrophils.
To get further insight to the role of neutrophil activation
in the pathogenesis of PUUV-HFRS by we correlated the
acute plasma levels of MPO, HNE, histone H3, and IL-8 to
variables reflecting severity of AKI (maximum plasma creatinine
level measured during the hospital stay), and to hematological
variables (minimum blood platelet count, maximum blood
leukocyte count, and plasma tissue plasminogen activator (tPA)
level) (Table 1). We found that HNE and histone H3 positively
correlated with the severity of AKI. In addition, MPO and
HNE correlated with all the tested hematological variables. Not
surprisingly, given the likely neutrophil origin of MPO and HNE,
they also correlated strongly with each other. The acute IL-8
levels correlated significantly with low platelets and exceptionally
strongly with MPO, HNE and histones (p < 0.005 for all)
suggesting that IL-8 could play a role in neutrophil activation.
Localization of MPO, HNE, and IL-8 in the
Kidneys of Acute PUUV-HFRS
In order to investigate whether markers of neutrophil activation
could also be detected in tissues of patients suffering from
acute PUUV-HFRS, we made use of archival biopsies to detect
the expression of MPO, HNE and IL-8 in patient kidneys by
immunohistochemistry. We did not include histones in this
analysis since we expected that differentiating NET-associated
histones from viable cells would be challenging. Elevated
expression of MPO, HNE and IL-8 could be detected more
readily in acute PUUV-HFRS patients than PUUV-negative
control patient samples (Figure 2A). By counting the tissue
area staining positive for MPO, HNE, or IL-8 we could
observe a statistically significant difference in MPO expression
between PUUV positive and negative cases (n = 5; p = 0.04;
Figure 2B). In the case of HNE and IL-8 higher expression
was found in 2 and 3 PUUV cases, respectively, as compared
to controls but this was not enough to reach statistical
significance (n = 5; p = 0.08 and p = 0.15, respectively).
The most prominent localization of MPO, HNE and IL-
8 in HFRS patients was the tubulointerstitial space, in line
with the diagnosis of tubulointerstitial nephritis. Therein we
could observe both cell-associated (arrowheads) and extracellular
expression (filled arrows) of MPO and HNE suggesting both
neutrophil infiltration and activation, respectively. Interestingly,
HNE and IL-8 localized also to in the tubular epithelial cells in
two HFRS patients (empty arrows). IL-8 could also occasionally
be observed in the tubular cells of PUUV-negative patients albeit
with a lower intensity and frequency as compared to HFRS
patients (Figures 2A,B). Taken together, these results show that
MPO is a component of the inflammatory response toward
PUUV in the kidneys of acute HFRS, possibly accompanied by
HNE and IL-8, and suggest that neutrophils (and their activation
products) infiltrate kidneys through the capillary endothelium.
In addition, the current findings together with our previous
observations of elevated IL-8 levels in urine of acute PUUV-
HFRS (28) suggest that IL-8 is produced locally by kidney
epithelial cells in PUUV-HFRS and likely acts as a chemotactic
factor inviting neutrophil recruitment and extravasation in the
kidney.
Live PUUV Does Not Activate Neutrophils
in vitro
It has been shown that HTNV can directly bind CD18 integrin on
neutrophils and induce NETosis (21). We wanted to determine
whether PUUV can also induce NETosis which could explain
our findings of neutrophil activation in acute PUUV-HFRS. We
did this by incubating mock- or PUUV-infected Vero E6 cell
culture supernatants or purified PUUV (with the same infectious
titer) with freshly isolated PMNs and subsequently quantified
the release of extracellular DNA from PMNs. NETosis was
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FIGURE 1 | Circulating levels of MPO, HNE, histone H3 and IL-8 in PUUV-HFRS. Plots of the acute (median days after onset of fever 4 ± 2) and recovery stage
(15–30 days post onset) levels of MPO (A), HNE (B), histones (C) or IL-8 (D) in PUUV-infected patient plasma samples (n = 32, 30, 53 and 36, respectively) as
compared to healthy controls (n = 5, 5, 5, and 8, respectively) distributions across groups were compared by Kruskal-Wallis H test and statistically significant
differences indicated as either *p < 0.05 or **p < 0.01.
clearly induced above mock control by PUUV-containing Vero
E6 supernatant but not with purified PUUV (Figure 3A). To
elaborate on the finding that live PUUV does not cause NETosis,
UV-inactivation of PUUV-infected Vero E6 supernatant did not
affect its ability to induce NETosis (Figure 3B). These findings
indicate that live PUUV alone is not capable of inducing NETosis
but instead involves other factor/s released from hantavirus-
infected Vero E6 cells supernatants which might act alone or
synergistically with the inactivated virus. In order to analyze
whether purified hantaviruses could induce PMN degranulation
we incubated fresh PMNs with purified PUUV, TULV, HTNV,
or PMA (as a positive control) and analyzed peroxidase activity
in cell supernatants (Figure 3B). MPO activity was induced by
PMA but not with any of the hantaviruses tested, suggesting that
hantavirus do not induce significant PMN degranulation. These
results imply that neutrophil activation in HFRS is not caused
by direct contact with hantavirus but instead requires additional
factors. Thus, we wanted to analyze whether PUUV-infected
endothelial cells could play a role in neutrophil activation during
HFRS.
PUUV Induces a Pro-Inflammatory
Phenotype in BECs
Endothelial cells are the prime target of hantavirus infection in
vivo (2, 3). Thus, we hypothesized that PUUV could mediate
neutrophil activation through infected endothelial cells. To
test this, we either mock-infected or infected primary blood
endothelial cells (BECs) with purified live PUUV or UV-
inactivated PUUV (UV-PUUV). By visualizing the expression of
viral nucleocapsid protein N in the cells by immunofluorescence
we observed that BECs were close to 100% infected at 3 days post
infection (dpi), followed by significant drop in infectivity levels
at 6 dpi (Figure 4A). The downregulation of PUUV infection
in BECs is type I interferon-mediated, as reported previously
(29), and is probably due to MxA protein sequestering the viral
N protein (30) We analyzed the supernatants of infected BECs
for the presence of IL-8 by ELISA and observed that BECs
infected with live PUUV upregulate the secretion of IL-8 at 3
dpi as compared to mock- or UV-PUUV infections (Figure 4B).
However, longer culturing of mock- or UV-PUUV infected BECs
also upregulated IL-8 in the cell supernatants which finally led to
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TABLE 1 | Correlation between different clinical variables reflecting HFRS disease severity and markers of neutrophil activation.
Creatinine (max) Platelets (min) Leukocyte count (max) tPA MPO HNE Histones IL-8
MPO r 0.215 −0.582** 0.405** 0.571* 1.000 0.363** 0.329* 0.659**
Sig. 0.123 0.000 0.003 0.021 0.008 0.016 0.000
n 53 52 52 16 53 53 53 36
HNE r 0.364** −0.420** 0.296* 0.636** 0.363** 1.000 0.130 0.474**
Sig. 0.007 0.002 0.033 0.008 0.008 0.352 0.004
n 53 52 52 16 53 53 53 36
Histones r 0.228* −0.260 0.273 −0.101 0.329* 0.130 1.000 0.464**
Sig. 0.036 0.063 0.050 0.632 0.016 0.352 0.004
n 53 52 52 16 53 53 53 36
IL-8 r 0.138 −0.379* 0.292 0.536 0.659** 0.474** 0.464** 1.000
Sig. 0.423 0.025 0.089 0.089 0.000 0.004 0.004
n 36 35 35 11 36 36 36 36
The clinical variables creatinine, platelet and leukocyte counts are maximum or minimum values from the course of hospital stay whereas tPA and markers of neutrophil activation are
from 1st day of hospitalization. r, Spearman’s rho correlation coefficient; Sig., Significance of correlation (p); n, number of patients; MPO, Myeloperoxidase; HNE, Neutrophil elastase;
IL-8, Interleukin-8; tPA, Tissue plasminogen activator; *p < 0.05, **p < 0.01.
comparable, high levels of IL-8 irrespective of PUUV infection at
6 dpi. Since IL-8 could act as a general marker of inflammation
(10), we wanted to see whether PUUV-infected BECs would
upregulate also other inflammatory factors potentially important
for neutrophil recruitment. Thus we assessed the expression
of ICAM-1, a ligand for neutrophil-expressed CD11b/CD18
integrin complex, on the plasma membrane of BECs by
immunofluorescence-based imaging and quantification assays.
We found elevated levels ICAM-1 on the surface of PUUV-
infected BECs as compared to mock- or UV-PUUV infected
BECs at 3 dpi (Figure 4C). The elevated ICAM-1 levels remained
only slightly lower as compared to TNF-α treated BECs, used
as a positive control. At 6 dpi, ICAM-1 expression returned
to baseline levels in PUUV-infected BECs concomitantly with
the reduction of viral replication. As expected, TNF-α was
found to be a robust inducer of ICAM-1 in BECs and thus we
hypothesized that TNF-α could induce ICAM-1 also in PUUV-
infected BECs. However, we did not find any evidence for TNF-α
in PUUV-infected BEC supernatants by ELISA suggesting that
the induction of ICAM-1 in PUUV-infected BECs is independent
of this cytokine (data not shown).
PMNs Adhere to PUUV-Infected BECs
Next, we wanted to determine whether freshly isolated PMNs
(containing mainly neutrophils) could adhere to PUUV-infected
BECs which express elevated levels of IL-8 and ICAM-1. Fresh
PMNs were incubated with mock-, UV-PUUV or live PUUV-
infected BECs for 1 h, non-bound PMNs removed by washing
and remaining numbers of BEC-bound PMNs determined by
immunofluorescence-based imaging and quantitation of MPO
(used as a marker of PMNs). In addition to MPO, bound
PMNs were differentiated from BECs based on their segmented
nuclear morphology by DNA staining. We found that PMN
binding to PUUV-infected BECs was significantly elevated as
compared to mock- or UV-PUUV infected BECs at 3 dpi,
but not at 6 dpi (Figures 5A,B), consistent with the elevated
expression of ICAM-1 and higher virus replication in PUUV-
infected BECs at 3 dpi. As positive and negative controls, we used
TNF-α treated BECs and PUUV infected-BECs without PMN
incubation, respectively. Based on these results we consistently
allowed PMNs to bind the 3-day BEC cultures for 1 h in the
following experiments assessing PMN-BEC interaction as shown
in Figure 5.
We wanted to analyze further whether the binding of PMNs
to PUUV-infected BECs is mediated by chemotactic signals
driven by IL-8 and/or is dependent of the neutrophil-expressed
CD11b/CD18 binding to ICAM-1 on BECs. We did this by
incubating PMNs with either BECs infected with either live
PUUV or UV-PUUV as the negative control for infection in
the presence of neutralizing antibodies to IL-8 or CD18. We
could determine that binding to PUUV-infected BECs was
dependent on CD11b/CD18 on neutrophils but not on the
presence of IL-8 (Figures 5A,C). Not surprisingly, CD11b/CD18
seemed to mediate the adhesion of PMNs also to TNF-α treated
BECs, although less dramatically (Figure 5D). The fact that
CD18 neutralizing antibody was not as efficient in blocking
PMN adhesion to TNF-α treated BECs could be due to the
excess level of ICAM-1 upregulated by TNF-α as compared
to PUUV infection (Figure 4C). Given that HTNV has been
shown to bind CD18 integrin (21) we also tested the effect
of viral glycoprotein (Gn and Gc) neutralizing antibodies (31)
on PMN-BEC interaction. However, we could not observe
any significant effects (Figure 5E) by Gn or Gc neutralizing
antibodies suggesting that PMN adhesion to infected BECs is
mediated by host-derived inflammatory factors but not viral
proteins. Unfortunately, we could not reliably determine the
role of ICAM-1 in PMN-BEC interaction since the presence of
ICAM-1 specific antibodies resulted in further elevated binding
of PMNs to BECs regardless of BECs being infected with PUUV
or not (data not shown). We hypothesize that this phenomenon
could be due to antibody-mediated cross-linking of neutrophil-
and BEC-associated ICAM-1 proteins. In addition, ICAM-1
antibodies are known to activate cross-linking and activation
Frontiers in Immunology | www.frontiersin.org 6 September 2018 | Volume 9 | Article 2098
Strandin et al. Neutrophil Activation in HFRS
FIGURE 2 | Immunohistochemical analysis of MPO, HNE and IL-8 in kidney sections from patients with acute PUUV-HFRS. Kidney sections from acute PUUV-HFRS
or unrelated kidney diseases (n = 5 for both) were analyzed for the presence of MPO, HNE or IL-8 by standard immunohistochemical techniques and visualized by
DAB staining. (A) Images from three cases with acute PUUV-HFRS and one PUUV-negative control section is shown. (B) The tissue area positive for MPO, HNE or
IL-8 was evaluated as percentages in all sections and mean values ± standard deviation reported for acute PUUV-HFRS and PUUV-negative sections. Significant
differences were assessed by student’s T-test and statistically significant differences indicated as *p < 0.05.
of ECs on cell surfaces in some conditions (32) which could
potentially explain this finding.
PUUV-Infected BECs Induce PMN
Degranulation
Next, we wanted to determine whether more extensive co-
culturing of PMNs and PUUV-infected BECs could result in
PMN activation (degranulation or NETosis) which could explain
our findings of increased levels of extracellular neutrophil
markers in PUUV-HFRS patients (Figures 1, 2). We observed
a time-dependent morphological change in PMNs bound to
PUUV-infected BECs but not in mock- or UV-PUUV infected
BECs which was visible after 3 but not 1 h of co-culture
(Figures 6A,B). This was evident by increased nuclear swelling of
PMNs together with altered localization of MPO from diffuse to
plasma membrane-associated staining. Furthermore, MPO could
be observed also extracellularly, which strongly suggests that
PMN degranulation was taking place. The fluorescent phenotype
of PMNs bound to PUUV-infected BECs was strikingly similar
although less pronounced as observed for PMNs bound to
TNF-α treated cells after a 3 h of co-culture. We did not
find any evidence for NETosis in PMNs bound either on
PUUV-infected or TNF-α treated cells or by PUUV-infected
BEC supernatants (data not shown) in these experimental
conditions.
Antiviral Effect of PMNs Is Mediated by
Protease Release in vitro
Finally, we wanted to determine whether neutrophils possess
antiviral function and if so, by which mechanism. We incubated
purified PUUV with freshly isolated PMNs, which were either
non-activated or activated with PMA. Furthermore, incubations
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FIGURE 3 | Live PUUV does not induce neutrophil activation. (A) Mock- or PUUV-containing Vero E6 supernatants (Sup) or purified PUUV were incubated with freshly
isolated PMNs for 3 h (MOI 1) (n = 2). The release of extracellular DNA was assessed by an impermeable DNA binding fluorescent dye. (B) Mock-, live PUUV- or
UV-inactivated PUUV-containing Vero E6 supernatants were incubated with PMNs and assessed for DNA release as in (A) (n = 3). (C) Purified PUUV, TULV or HTNV
were incubated with fresh PMNs for 3 h (MOI 1) and peroxidase activity assessed from cell culture supernatants by TMB (n = 3). PMA-treated PMNs were used as a
positive controls. Difference between groups were assessed by one-way ANOVA + Dunnett’s multiple comparisons test and statistically significant differences
indicated as either *p < 0.05 or **p < 0.01.
FIGURE 4 | PUUV infection causes pro-inflammatory responses in BECs. (A) BECs were either mock-infected or infected with live or UV-inactivated PUUV (UV-PUUV)
and assessed for viral nucleocapsid protein expression at 3 and 6 days post infection by immunofluorescence (red). The nuclei of BECs were visualized with Hoechst
33420 (blue). (B) IL-8 was measured from the respective supernatants of mock, UV-PUUV or PUUV-infected BECs by ELISA. (C) ICAM-1 expression in TNF-α treated
or mock-, UV-PUUV or PUUV-infected BECs was visualized by immunofluorescence (green) and shown as an overlay with Hoechst 33258 staining (blue).
Fluorescence intensity of ICAM-1 expression on BECs was quantified and reported as fold change to mock-infected cells. Differences between groups were assessed
by one-way ANOVA with Dunnett’s multiple comparisons test and statistically significant differences indicated as **p < 0.01. n = 2 in all panels. Results shown are
representatives of three independent experiments.
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FIGURE 5 | Binding of quiescent PMNs to PUUV-infected BECs. Freshly isolated PMNs were allowed to bind to mock-, UV-PUUV or live PUUV-infected BECs for 1 h
at 3 or 6 days post infection (dpi). (A) PMNs bound to either TNF-α treated, UV-PUUV or PUUV-infected BECs were visualized at 3 dpi by immunofluorescence using
MPO-specific antibody. The nuclei were stained with Hoechst 33420. (B) BEC-bound PMNs were quantified at 3 and 6 dpi as fold change to mock-infected cells. (C)
PMNs were allowed to bind to PUUV-infected BECs at 3 days post infection in the presence of neutralizing antibodies to IL-8, CD18 or an isotype control and
quantified as above. (D) PMNs were allowed to bind to BECs treated with TNF-α for 3 days in the presence or absence of CD18 antibody and quantified as above. (E)
PMNs were allowed to bind at 3 days post infection to PUUV-infected BECs treated with Gn- or Gc-specific neutralizing antibodies and quantified as above.
Statistically significant differences between groups were assessed either by student’s T-test (B,D) or one-way ANOVA with Dunnett’s multiple comparison test (C,E)
and indicated as **p < 0.01. n = 2 in all panels. Results shown are representatives of three independent experiments.
of virus with PMA-activated PMNs were performed in the
presence of one of the following inhibitors: NaN3 (an inhibitor
ofMPO activity), phenylmethylsulfonylfluoride (PMSF; inhibitor
of serine proteases), EDTA (inhibitor of metalloproteinases) and
DNAse (degradation of NETs). After incubation, samples were
subjected to immunoblotting in order to detect degradation of
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FIGURE 6 | PUUV-infected BECs induce PMN degranulation. (A) PMNs were allowed to bind to mock- or PUUV-infected BECs at 3 days post infection for 1 or 3 h.
BECs treated with TNF-α for 1 day and exposed to PMNs for 3 h were used positive control for PMN activation. PMN activation was assessed by morphological
changes of bound PMNs as observed by immunofluorescence staining for MPO (red) and nuclei (Hoechst 33420, blue). On the right, the fluorescence image of one
individual BEC-bound PMN from each treatment group is enlarged for better visualization of PMN activation. (B) The percentage of swollen nuclei with concomitant
changes in MPO expression from diffuse cytoplasmic to plasma membrane localization were counted in individual wells and mean values ± standard deviation
reported. Statistically significant differences between groups is assessed by student’s T-test and indicated as **p < 0.01. n = 3. Results shown are representatives of
two independent experiments.
viral structural proteins Gn, Gc and N protein (Figure 7A) and
virus titer determinations in Vero E6 cells (Figure 7B). The
PUUV Gc and N proteins migrated as expected based on their
molecular size of ∼54 and 50 kDa, respectively, whereas Gn
is known to form SDS-stabile tetramers of ∼240 kDa in SDS-
PAGE [Figure 7A, (27)]. PMA-treated PMNs complete destroyed
PUUV infectivity and the surface glycoproteins Gn and Gc while
it has almost no effect on N protein, which is retained inside
the virus particle, whereas quiescent PMNs decreased PUUV
viability only marginally (50%) with the concomitant low-level
cleavage of Gc. PMSF totally blocked the cleavage of Gn and
Gc while retaining almost 10% of PUUV infectivity indicating
strong involvement of serine proteases (such as HNE) in the
antiviral effect of activated PMNs. Also, EDTA treatment retained
significant levels of infectivity (5%) although not being able to
block the degradation of Gn andGc significantly. However, NaN3
or DNAse treatments had no effect on the ability of PMA-treated
PMNs to kill virus or degrade its glycoproteins, indicating that
MPO or the formation of NETs do not play a direct role in
the antiviral effects of PMNs in this experimental setup. The
fact that the infectivity of PUUV was not significantly reduced
after treatment with quiescent PMNs is further proof (see
Figure 3) that hantaviruses are unable to significantly activate
PMNs.
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FIGURE 7 | Antiviral activity of activated PMNs. Purified PUUV was incubated
with quiescent or PMA-activated freshly isolated PMNs in the presence of
inhibitors for MPO (0.01 or 0.002% NaN3), serine proteases (1 or 0.2mM
PMSF), metalloproteinases (1mM EDTA) or NETs (10 U/ml DNAse) and (A)
subjected to immunoblotting for viral proteins Gn, Gc and N protein and
infectious titer measurement in Vero E6 cells (B). C, Control without the
addition of PMNs.
DISCUSSION
We observed elevated levels of circulating extracellular MPO,
HNE and histones in the acute stage of PUUV-caused HFRS
as compared to the recovery stage and healthy controls. MPO
and HNE are expressed in neutrophil granules and released
to the extracellular space through neutrophil degranulation or
alternatively as components of NETs. Histones, on the other
hand, are essential components of NETs but could be also
released from other types of dying cells. The circulating levels
of histone H3 correlated with MPO and HNE suggesting that
all these factors are released simultaneously from neutrophils
during NETosis, which presence in acute PUUV-HFRS has been
reported previously (21). Interestingly, we found strong positive
correlations between the levels of HNE or histone H3 and
variable reflecting the severity of AKI (maximum creatinine);
indicating that neutrophils could play a role in mediating kidney
damage, the hallmark of HFRS. We could observe elevated
expression of MPO in kidneys of acute PUUV-HFRS where it
mainly localized to the interstitial space surrounding tubules,
supporting earlier findings that infiltration of neutrophils into
kidneys is a part of the inflammatory response toward PUUV (7).
In addition, we found that the major chemotactic factor for
neutrophils, IL-8, is upregulated in the acute stage of PUUV-
HFRS in blood, as previously reported (33), and correlated
strongly with neutrophil activation markers (MPO, HNE and
histone H3). This was also accompanied by a tendency of
higher IL-8 expression also in the kidneys of acute PUUV-
HFRS patients. The kidney IL-8 was found to be localized to
the tubulointerstitial space, similarly to MPO and HNE, but also
to tubular epithelial cells. This suggests IL-8 could be expressed
directly by the kidney in PUUV-HFRS and plays a major role
in recruiting neutrophils into this tissue. Furthermore, local
expression of IL-8 in the kidney probably explains the high levels
of IL-8 found in the urine of PUUV-HFRS patients (28).
AKI is the hallmark symptom of HFRS but the disease
manifests as systemic vascular dysfunction as indicated by
capillary leakage in several organs (1). It is of interest to
note that neutrophil activation markers not only correlate with
kidney injury, but also with different hematological parameters
indicating the extent of thrombocytopenia, leukocytosis and
fibrinolysis (low platelets, high leukocytes and high tPA,
respectively). This suggests that neutrophil activation either
contributes to or is in fact caused by the same underlying factors
which lead to capillary leakage in PUUV-HFRS and is not an
isolated phenomenon which effect would be restricted to the
kidney. This calls for future studies aimed at determining the
extent of neutrophil activation also in other forms of hantavirus-
mediated diseases such as HCPS which severely affect lungs
instead of kidneys. In fact, neutrophils have been shown as
the main culprits of pulmonary vascular permeability in mouse
model of HTNV infection (25).
A previous report indicates that HTNV binds CD11b/CD18
integrin complex on the surface of neutrophils and, as shown
using HTNV-containing Vero E6 cell culture supernatants,
activates NETosis in freshly isolated PMNs (21). Given the
high degree of similarity between different hantaviruses (1), we
hypothesized that also PUUV is be able to activate in NET
formation in PMNs. However, we observed that, while PUUV-
containing Vero E6 cell culture supernatant was able to activate
NETosis, purified PUUV was not (Figure 3A), suggesting that
NETosis is not mediated by live, intact virus but rather other
factor/s present in the cell culture supernatant of infected Vero
E6 cells. We therefore sought for an alternative mechanism of
neutrophil activation in PUUV-HFRS and turned our attention
toward microvascular endothelial cells, the prime target of
hantavirus infection in vivo. To begin with, we found that PUUV-
infected bloodmicrovascular cells (BECs) secreted elevated levels
of IL-8 and expressed more ICAM-1 on their surface than
non-infected BECs; suggesting that PUUV infection induces
a pro-inflammatory phenotype in BECs. Importantly, elevated
expression of ICAM-1 has been also detected in kidneys of
acute PUUV-HFRS (8). We observed that freshly isolated PMNs
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adhered to PUUV-infected, pro-inflammatory BECs which was
dependent on CD11b/CD18 integrin complex on the surface of
neutrophils but not IL-8 or viral glycoproteins. We then asked
whether the BEC-adhered PMNs would become activated to
explain the observed elevated levels of MPO, HNE and histones
in patients. We found that extensive co-culturing of fresh PMNs
together with PUUV-infected BECs resulted in morphological
changes in PMNs, which suggested degranulation of PMNs.
However, we did not find any evidence of increased NETosis in
these co-cultures.
These results imply that PUUV infection causes pro-
inflammatory changes in endothelial cells to attract and
activate neutrophils on the surface of the endothelium by an
IL-8 dependent mechanism. It is previously noted that pro-
inflammatory endothelial cells can induce NETosis partially
through EC-derived IL-8 causing endothelial cell death (34).
The interactions of neutrophils with the endothelium in
inflammatory conditions is well-documented (9, 12, 35, 36) and
typically these events are not associated with clinically significant
vascular permeability. In typical inflammatory reactions,
however, the chemotactic signals that induce inflammation
originate from tissues from where neutrophil diapedesis across
the endothelium is locally dictated. This is in contrast to
hantavirus infections where the viruses replicate in endothelial
cells to cause systemic inflammation of the vasculature. In
addition to endothelial cells, hantavirus glycoproteins have been
detected in renal tubular cells in acute HTNV-caused HFRS
(37), where we observed increased levels of HNE and IL-8 in
this study, suggesting that hantavirus-infected tubular cells
could behave similarly to infected endothelial cells and recruit
and activate neutrophils by an IL-8 dependent mechanism.
The fact that depletion of neutrophils suppress lung pathology
in a mouse model for HTNV certainly supports the idea of
neutrophils as the driving force of HFRS pathogenesis (25).
Similar mechanisms could play a role also in other hemorrhagic
fevers (38). It is known that for instance that flavi- and filoviruses
induce pro-inflammatory changes in endothelial cells (39–41).
Of note, ICAM-1 polymorphism is associated with dengue
disease severity (42).
Neutrophils are well-known for their antibacterial effects but
their ability to counteract viral infections are only beginning to
be unraveled (17, 35, 43). Early research indicates that defensins,
which are peptides released from neutrophils upon activation,
show antiviral activity against enveloped viruses (44). MPO can
also cause oxidative damage to viruses upon neutrophil oxidative
burst and degranulation (45). Lately, the antiviral effects of NETs
have been implicated (46). In the present study we observed
that serine proteases (such as HNE) play a major role in the
virucidal function of neutrophils against PUUV. However, we did
not obtain evidence for a direct role of NETs or MPO-mediated
oxidative effects in killing PUUV. Furthermore, the fact that
PUUV was not killed by PMNs which were non-activated at the
start of the experiment, show that PUUV doesn’t directly cause
significant protease release by PMNs. The inability of PMNs to
produce NETs through direct contact with hantaviruses is not
surprising since typically NETs are produced in response to larger
microbes (47) but given the known expression of several Toll-like
receptors by neutrophils (48), their inability to release proteases
(degranulate) in response to PUUV is peculiar. However, some
viruses are known to block the activation of neutrophils (49, 50)
and whether this is also the case for hantaviruses remain a topic
for future studies.
To conclude, we have found that patients suffering from
acute PUUV-caused HFRS show elevated levels of circulating
MPO, HNE, histone H3 and IL-8 indicating neutrophil activation
through degranulation and/or NETosis. The expression levels
of these markers positively correlate with parameters reflecting
disease severity suggesting that neutrophil activation could play
a major role in the pathogenesis of HFRS. Mechanistically,
our data indicates that neutrophil activation is more likely to
occur indirectly via virus-infected microvascular endothelial cells
rather than directly through virus contact with neutrophils.
Future studies are still needed to elucidate whether either
neutrophil degranulation or NETosis has the stronger impact on
hantavirus pathogenesis.
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